ZURICHNovartis AG said Sunday that the head of its cancer business had left the company for a new job creating a vacancy at the top of one of its most important franchises  Baselbased Novartis said Herv Hoppenot who had been president of Novartis Oncology since  would be replaced on an interim basis by Alessandro Riva who is in charge of the units development and medical affairs  A
  